Wieder, Hinrich
16  Ergebnisse:
Personensuche X
?
3

Molecular Imaging of Proliferation and Glucose Utilization:..:

Ott, Katja ; Herrmann, Ken ; Schuster, Tibor...
Annals of Surgical Oncology.  18 (2011)  12 - p. 3316-3323 , 2011
 
?
 
?
5

Prediction of tumour response by FDG-PET in patients with a..:

Wieder, Hinrich ; Weber, Wolfgang
European Journal of Nuclear Medicine and Molecular Imaging.  36 (2008)  1 - p. 158-159 , 2008
 
?
7

Prediction of tumor response by FDG-PET: comparison of the ..:

Wieder, Hinrich A. ; Ott, Katja ; Lordick, Florian...
European Journal of Nuclear Medicine and Molecular Imaging.  34 (2007)  12 - p. 1925-1932 , 2007
 
?
8

PET/CT with Gluc-Lys-([18F]FP)-TOCA: correlation between up..:

Wieder, Hinrich ; Beer, Ambros J. ; Poethko, Thorsten...
European Journal of Nuclear Medicine and Molecular Imaging.  35 (2007)  2 - p. 264-271 , 2007
 
?
9

Monitoring chemotherapy and radiotherapy of solid tumors:

Weber, Wolfgang A. ; Wieder, Hinrich
European Journal of Nuclear Medicine and Molecular Imaging.  33 (2006)  S1 - p. 27-37 , 2006
 
?
10

PET imaging with [18F]3′-deoxy-3′-fluorothymidine for predi..:

Wieder, Hinrich A. ; Geinitz, Hans ; Rosenberg, Robert...
European Journal of Nuclear Medicine and Molecular Imaging.  34 (2006)  6 - p. 878-883 , 2006
 
?
11

PET imaging with [11C]methyl-L-methionine for therapy monit..:

Wieder, Hinrich ; Ott, Katja ; Zimmermann, Frank...
European Journal of Nuclear Medicine and Molecular Imaging.  29 (2002)  6 - p. 789-796 , 2002
 
?
14

Clinical use of bone-targeting radiopharmaceuticals with fo..:

Herrmann, Ken ; Wieder, Hinrich A ; Lassmann, Michael..
https://opus.bibliothek.uni-wuerzburg.de/frontdoor/index/index/docId/11301.  , 2014
 
1-15